SAEROF: an ensemble approach for large-scale drug-disease association prediction by incorporating rotation forest and sparse autoencoder deep neural network

• Published in: Scientific reports Vol. 10; no. 1; p. 4972
• Main Authors: Jiang, Han-Jing, Huang, Yu-An, You, Zhu-Hong
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 18.03.2020; Nature Publishing Group
• Subjects: 631/114/2413; 692/4017; Algorithms; Anti-Obesity Agents - pharmacology; Antineoplastic Agents - pharmacology; Area Under Curve; Computational Biology - methods; Computer applications; Computer Simulation; Databases, Factual; Experimental methods; Gastric cancer; Humanities and Social Sciences; Humans; Lung cancer; Lung Neoplasms - drug therapy; Machine Learning; Mathematical models; multidisciplinary; Neural networks; Neural Networks, Computer; Obesity - drug therapy; Performance evaluation; ROC Curve; Science; Science (multidisciplinary); Stomach Neoplasms - drug therapy; Support Vector Machine; Tumors
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-020-61616-9

Drug-disease association is an important piece of information which participates in all stages of drug repositioning. Although the number of drug-disease associations identified by high-throughput technologies is increasing, the experimental methods are time consuming and expensive. As supplement to them, many computational methods have been developed for an accurate in silico prediction for new drug-disease associations. In this work, we present a novel computational model combining sparse auto-encoder and rotation forest (SAEROF) to predict drug-disease association. Gaussian interaction profile kernel similarity, drug structure similarity and disease semantic similarity were extracted for exploring the association among drugs and diseases. On this basis, a rotation forest classifier based on sparse auto-encoder is proposed to predict the association between drugs and diseases. In order to evaluate the performance of the proposed model, we used it to implement 10-fold cross validation on two golden standard datasets, Fdataset and Cdataset. As a result, the proposed model achieved AUCs (Area Under the ROC Curve) of Fdataset and Cdataset are 0.9092 and 0.9323, respectively. For performance evaluation, we compared SAEROF with the state-of-the-art support vector machine (SVM) classifier and some existing computational models. Three human diseases (Obesity, Stomach Neoplasms and Lung Neoplasms) were explored in case studies. As a result, more than half of the top 20 drugs predicted were successfully confirmed by the Comparative Toxicogenomics Database(CTD database). This model is a feasible and effective method to predict drug-disease correlation, and its performance is significantly improved compared with existing methods.